StockData
Gelteq Ltd logo

Gelteq Ltd (GELS) stock

GELSNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through fiscal 2025, year ended Jun 30, 2025Last filing: 20-F on Nov 16, 2026Score 0/30
$0.27−0.09 (-25.05%)

Close on Nov 17, 2026Market cap $2.88MP/E –Yield –

Gelteq cash

Cash and short-term investments held at the end of each period.

Gelteq's cash was A$9.35K at Dec 31, 2025. For fiscal 2025 it was A$344.65K, up 1305.5% from the year before.

Annual cash

PeriodPeriod endValueChange
FY2025Jun 30, 2025A$344.65K+1305.5%
FY2024Jun 30, 2024A$24.52K-93.9%
FY2023Jun 30, 2023A$399.22K+145.7%
FY2022Jun 30, 2022A$162.49K–

Quarterly cash

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2026CQ4 2025Dec 31, 2025A$9.35K-92.6%
Q4 FY2025CQ2 2025Jun 30, 2025A$344.65K-13.7%
Q2 FY2025CQ4 2024Dec 31, 2024A$3.05M+1775.0%
Q4 FY2024CQ2 2024Jun 30, 2024A$24.52K–
Q2 FY2024CQ4 2023Dec 31, 2023A$126.78K–
Q4 FY2023CQ2 2023Jun 30, 2023A$399.22K–
Q4 FY2022CQ2 2022Jun 30, 2022A$162.49K–

More Gelteq figures

See a number that looks wrong?